News

Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.
Here’s what experts say you should know about DIM, "good" estrogens and the future of hormone support in midlife and beyond. That ‘Natural’ Supplement Might Be Messing With Your Hormones DIM is a ...
Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...
From celebrity talk shows to social feeds, it may feel like everyone is talking about perimenopause and menopause these days.
At the intersection of aesthetics and science, RegenCen is changing how patients think about aging. Born from a fusion of ...
Testosterone propionate was once a common treatment for men with low testosterone. It’s a synthetic version of the naturally ...
Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.
Another study (JAMA Network Open, July 1, 2025) also found that estrogen plus progestin was associated with an increase in ...
A new study suggests that hormone therapy, often used to ease symptoms of menopause like hot flashes and night sweats, may ...
Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...